Lv11
72 积分 2024-02-28 加入
Evaluation of Double Self-Immolative Linker-Based Antibody–Drug Conjugate FDA022-BB05 with Enhanced Therapeutic Potential
2天前
已完结
Cathepsin B: Active site mapping with peptidic substrates and inhibitors
6天前
已完结
Legumain-Cleavable Top1i Antibody-Drug Conjugates without Self-Immolative Spacers Demonstrate Potent Antitumor Activity
6天前
已完结
ADME and Safety Aspects of Non-cleavable Linkers in Drug Discovery and Development
19天前
已完结
Non-cleavable Linkers: Permanently Linked, for Better or for Worse
19天前
已完结
Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα)
25天前
已完结
A chemoenzymatic approach toward the preparation of site-specific antibody–drug conjugates
25天前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
26天前
已完结
Degrader-antibody conjugates
26天前
已完结
Linker Design for The Antibody Drug Conjugates: A Comprehensive Review
30天前
已完结
How does equity restriction affect innovation quality? Evidence from listed manufacturing companies in China
皖公网安备34019202002308
